Shanghai Fosun Pharmaceutical Group Co Ltd (600196.SS) Quote| Reuters.com
Edition:
United States

Shanghai Fosun Pharmaceutical Group Co Ltd (600196.SS)

600196.SS on Shanghai Stock Exchange

19.02CNY
30 Jun 2016
Change (% chg)

¥0.19 (+1.01%)
Prev Close
¥18.83
Open
¥18.84
Day's High
¥19.12
Day's Low
¥18.84
Volume
6,658,491
Avg. Vol
9,406,064
52-wk High
¥29.94
52-wk Low
¥16.50

600196.SS

Chart for 600196.SS

About

Shanghai Fosun Pharmaceutical (Group) Co., Ltd is a China-based company engaged in research, development, production and sale of pharmaceuticals. The Company's products are mainly used in the treatment of metabolism and digestive tract system, cardiovascular system, central nervous system, blood system and anti-infection... (more)

Overall

Beta: 0.73
Market Cap(Mil.): ¥42,349.88
Shares Outstanding(Mil.): 2,314.07
Dividend: 0.32
Yield (%): 1.70

Financials

  600196.SS Industry Sector
P/E (TTM): 17.17 34.76 35.71
EPS (TTM): 1.10 -- --
ROI: 11.48 15.00 14.23
ROE: 14.13 16.06 15.43

BRIEF-Shanghai Fosun Pharmaceutical plans to list Israel unit in Hong Kong

June 29 Shanghai Fosun Pharmaceutical Group Co Ltd

Jun 29 2016

BRIEF-Shanghai Fosun Pharmaceutical (Group) unit gets nod for clinic trial

June 20 Shanghai Fosun Pharmaceutical (Group) Co., Ltd:

Jun 19 2016

BRIEF-Shanghai Fosun Pharmaceutical Group to provide $50 mln loan guarantee for unit

June 14 Shanghai Fosun Pharmaceutical Group Co Ltd :

Jun 14 2016

BRIEF-Shanghai Fosun Pharmaceutical Group unit receives drug approval for clinical trial

May 30 Shanghai Fosun Pharmaceutical Group Co., Ltd:

May 29 2016

BRIEF-Shanghai Fosun Pharmaceutical Group issues 500 mln yuan worth super short-term debentures

May 24 Shanghai Fosun Pharmaceutical Group Co., Ltd:

May 24 2016

BRIEF-Shanghai Fosun Pharmaceutical Group units get nod for clinic trial

May 18 Shanghai Fosun Pharmaceutical Group Co., Ltd. :

May 17 2016

BRIEF-Shanghai Fosun Pharmaceutical Group unit gets nod for clinic trial

May 18 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. :

May 17 2016

BRIEF-Shanghai Fosun Pharmaceutical to issue up to 6.0 bln yuan bonds

April 11 Shanghai Fosun Pharmaceutical Group Co Ltd

Apr 11 2016

BRIEF-Shanghai Fosun Pharma's 2015 net profit up 16.4 pct y/y

March 29 Shanghai Fosun Pharmaceutical Group Co Ltd

Mar 29 2016

BRIEF-Shanghai Fosun Pharma to buy stake in pharma firm

March 15 Shanghai Fosun Pharmaceutical Group Co Ltd

Mar 15 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Sadif Analytics Prime
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.